(Q43523794)

24 November 2017

title

The risk of developing second cancers among survivors of childhood soft tissue sarcoma (English)

1 reference

24 November 2017

2

Rochelle E Curtis

1 reference

24 November 2017

Randi J Cohen

1

1 reference

24 November 2017

Peter D Inskip

series ordinal

3

1 reference

24 November 2017

Joseph F Fraumeni

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

24 November 2017

1 reference

24 November 2017

volume

103

1 reference

24 November 2017

issue

11

1 reference

24 November 2017

page(s)

2391-2396

1 reference

Melanocytic naevi and melanoma in survivors of childhood cancer

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

21 January 2018

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second malignant neoplasms in children after treatment of soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Bone sarcomas linked to radiotherapy and chemotherapy in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Cutaneous melanoma in patients with sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Melanoma and soft tissue sarcoma in seven patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Clinical simulators of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Multiple primary cancers in families with Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21040

7 January 2021

Identifiers

DOI

10.1002/CNCR.21040

1 reference

24 November 2017

1 reference